Skip to main content

Alkermes Highlights Ongoing Investigational Immuno-oncology Clinical Trials

SOURCE: Alkermes

DESCRIPTION:

Alkermes is committed to researching and developing potential new cancer treatment options that may help address unmet patient needs. Clinical trials are an important step in evaluating the safety and efficacy of potential treatments. Learn more about the ongoing clinical trial program for our investigational immuno-oncology candidate: https://bit.ly/3pl8pkG

Tweet me: .@Alkermes is committed to researching and developing potential new cancer treatment options that may help address unmet patient needs. Learn more about the ongoing clinical trial program for our investigational immuno-oncology candidate: https://bit.ly/3qVBSkK

KEYWORDS: Alkermes, Immuno-Oncology, clinical research, NASDAQ:ALKS

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.